Athenex
(NASDAQ) ATNX
Athenex Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$119.83M
Net Income (TTM)
$102.89M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
ATNX News
Biotech’s Year-End To-Do List
ATNX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Athenex
Industry
Biotechnology
Sector
Health CareEmployees
280
CEO
Yiu Nam Lau, MD
Website
www.athenex.comHeadquarters
Buffalo, NY 14203, US
ATNX Financials
Key Financial Metrics (TTM)
Gross Margin
26%
Operating Margin
-68%
Net Income Margin
-96%
Return on Equity
22%
Return on Capital
-78%
Return on Assets
-49%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$26.70M
Operating Income
$69.94M
EBITDA
$72.42M
Operating Cash Flow
$75.01M
Capital Expenditure
$2.06M
Free Cash Flow
$77.07M
Cash & ST Invst.
$36.69M
Total Debt
$42.36M
Athenex Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$25.06M
+0.5%
Gross Profit
$6.88M
+62.2%
Gross Margin
27.45%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
269
N/A
Net Income
$28.77M
+70.4%
EBITDA
$16.59M
+81.9%
Quarterly Fundamentals
Net Cash
$5.67M
+95.0%
Accounts Receivable
$27.86M
+4.6%
Inventory
$42.65M
+23.0%
Long Term Debt
$3.14M
-97.1%
Short Term Debt
$39.21M
-21.2%
Return on Assets
-48.50%
N/A
Return on Invested Capital
-78.42%
N/A
Free Cash Flow
$14.34M
+51.6%
Operating Cash Flow
$14.39M
+62.5%